Skip to Main Content

Author Details

Steven Hazell
Royal Marsden NHS Foundation Trust
2011
41
21
PMIDPaper TitleJournal TitlePublished Year
34214236The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.BJU Int2022
34949820Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.Nat Ecol Evol2022
34002049Selection of metastasis competent subclones in the tumour interior.Nat Ecol Evol2021
33586998Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.Br J Radiol2021
32529651Prostate-specific membrane antigen expression in melanoma metastases.J Cutan Pathol2020
31812718Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial.Int J Radiat Oncol Biol Phys2020
32840422Squamous Non-Small-Cell Lung Cancer Molecularly Reclassified as Transdifferentiated Prostate Cancer Due to Identification of <i>TMPRSS2-ERG</i> Translocation With <i>SOX2</i> Amplification.JCO Oncol Pract2020
31493904Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT).Radiother Oncol2019
28753852DESNT: A Poor Prognosis Category of Human Prostate Cancer.Eur Urol Focus2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29656895Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.Cell2018
29656894Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.Cell2018
29656891Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.Cell2018
27221560Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI.Eur Radiol2017
28499792Doing More With Less; Are There Some 'Easy Wins' in the Management of Early Breast Cancer?Clin Oncol (R Coll Radiol)2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28761723Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.ESMO Open2017
27005674Two cases of gallbladder metastasis from renal cell carcinoma and review of literature.World J Surg Oncol2016
27151655The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.Oncologist2016
25041380Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial origin.Histopathology2015
26637887Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.Anticancer Res2015
26041862Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.J Clin Pathol2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25790038Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.Nat Commun2015
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
24487277Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.Nat Genet2014
26779560Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk.Eur J Radiol Open2014
25159823Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.Genome Biol2014
24788528Melanoma with rhabdomyosarcomatous differentiation: two further cases of a rare pathologic pitfall.Int J Surg Pathol2014
24582988Preoperative imaging in patients undergoing trachelectomy for cervical cancer: validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T.Gynecol Oncol2014
24587930Rhabdomyosarcoma with pseudolipoblasts arising in ovarian carcinosarcoma: a distinctive postchemotherapy morphologic variant mimicking pleomorphic liposarcoma.Case Rep Pathol2014
23868012Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique.Br J Cancer2013
24122851Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.J Pathol2013
21205983Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes.J Neurol Neurosurg Psychiatry2012
22852025Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.Ther Adv Urol2012
22328187Trends in pathologic outcomes after introduction of active surveillance in the UK: implication for focal therapy.Prostate2012
22346102Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options.Urol Ann2012
22142404Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focality in prostate cancer.J Endourol2012
21116296Tumor focality in prostate cancer: implications for focal therapy.Nat Rev Clin Oncol2011
21955852Focal therapy for prostate cancer: opportunities and uncertainties.Discov Med2011
22038995Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.Clin Cancer Res2011
  • 1 - 41 of 41

Recommended Authors

Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Career Start Year 2013
Number of shared co-authors 0
Susan Prendeville
University of Toronto
Career Start Year 2013
Number of shared co-authors 4
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 2
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 1
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 7
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 1
Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 5
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 3
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 5
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 1
Adeboye O Osunkoya
Emory University School of Medicine
Career Start Year 2002
Number of shared co-authors 2
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 6
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 5
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 4
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 7
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 11
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 7
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 5
David Clouston
Career Start Year 1995
Number of shared co-authors 4
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 8
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 20
Peter A Humphrey
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 3
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 7
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 18
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 6
John R Srigley
University of Toronto
Career Start Year 1980
Number of shared co-authors 5
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 16

Collaborators

David Nicol
The Royal Marsden Hospital
Co-authored papers 14
Charles Swanton
Francis Crick Institute
Co-authored papers 9
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 8
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 7
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 7
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 6
Andy G Lynch
University of St Andrews
Co-authored papers 6
Erik Mayer
Imperial Clinical Analytics
Co-authored papers 6
Naomi Livni
Royal Marsden NHS Foundation Trust
Co-authored papers 6
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 5
Sue Merson
Institute of Cancer Research
Co-authored papers 5
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 5
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 5
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 5
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Co-authored papers 5
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 5
Adam Butler
Wellcome Sanger Institute
Co-authored papers 5
Peter Van Loo
The Francis Crick Institute
Co-authored papers 5
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 5
Nening Dennis
Institute of Cancer Research
Co-authored papers 5
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 5
Hayley C Whitaker
University College London
Co-authored papers 5
Barbara Kremeyer
University College London
Co-authored papers 4
Charlie E Massie
University of Cambridge
Co-authored papers 4
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 4
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
David Jones
Wellcome Sanger Institute
Co-authored papers 4
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 4
Hayley J Luxton
University College London
Co-authored papers 4
Release 1.2